Key Financial Data Of Reporting Company

Daito Pharmaceutical Co., Ltd. - Filing #7579309

Concept 2022-09-01 to
2022-11-30
2022-06-01 to
2022-11-30
As at
2022-11-30
2021-06-01 to
2022-05-31
As at
2022-05-31
2021-09-01 to
2021-11-30
As at
2021-11-30
2021-06-01 to
2021-11-30
Key financial data of reporting company
Business results of reporting company
Net sales
23,367,000,000 JPY
43,464,000,000 JPY
22,463,000,000 JPY
Ordinary profit (loss)
2,752,000,000 JPY
6,729,000,000 JPY
3,981,000,000 JPY
Net assets
49,530,000,000 JPY
47,674,000,000 JPY
44,646,000,000 JPY
Total assets
71,124,000,000 JPY
64,939,000,000 JPY
60,961,000,000 JPY
Basic earnings (loss) per share
56.75
122.46
335.41
68.96
202.05
Diluted earnings per share
122.24
Equity-to-asset ratio
0.691 xbrli:pure
0.728 xbrli:pure
0.726 xbrli:pure
Net cash provided by (used in) operating activities
1,141,000,000 JPY
4,370,000,000 JPY
2,407,000,000 JPY
Net cash provided by (used in) investing activities
-1,545,000,000 JPY
-4,400,000,000 JPY
-1,276,000,000 JPY
Net cash provided by (used in) financing activities
1,871,000,000 JPY
989,000,000 JPY
-680,000,000 JPY
Cash and cash equivalents
5,882,000,000 JPY
4,381,000,000 JPY
3,820,000,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.